Clinical Trial Update: Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma [NA]

View source ↗

Summary

Clinical trial on intrathecal radioimmunotherapy, radiation therapy, and chemotherapy after surgery for medulloblastoma has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors | NA | Status: COMPLETED | Results posted: 2020-05-11